Case Studies
A Breakthrough Approach to Pelvic Fixation & Fusion 3
“The Bedrock technique has provided me an effective solution to manage my deformity patients with concomitant SI joint pain.”
*Consultant for SI-BONE Inc.
- Provider
- Robert Eastlack, MD.*
- Speciality
- Orthopedic Surgeon
- Facility
- Mayo Clinic
- Bio
-
Professor and Head, Division of Spine Surgery Co-Director,
Spine Surgery Fellowship Fellowship: Mayo Clinic, Rochester, MN Residency: University of San Diego Medical Center, San Diego, CA Medical School: Baylor College of Medicine, Houston, TX Robert Eastlack, MD, is an orthopedic surgeon and a fellowship-trained
spine specialist who focuses on minimally invasive and complex deformity reconstruction, as well as cervical spine reconstruction and deformity correction.
Case Details
- Condition
- Spinopelvic Fixation
- Product(s)
-
iFuse Bedrock Granite Implant System
- Patient
- 63 yo female
Congentical Deformity Revision Spinal Surgery
Patient History:
- 63 yo female with diabetes mellitus
- Congenital lumbar scoliosis and degenerative spondylolisthesis L4-5
- Prior surgery for cervical myelopathy
- Prior T10-pelvis fusion with S2AI screws
- Prior L4-5 TLIF
- Loosening of pelvic fixation and broken rod first evident 2 years post operatively
- Severe back and buttock pain, diminished walking tolerance and spinal deformity
- Bilateral SI joint pain confirmed with physical exam/diagnostic injections
Index Operation
Index Operation
Surgical Treatment:
- Revision lumbo-pelvic fixation with bilateral S2AI screws, kickstand rod on Right
- Bilateral iFuse 3D™ implants in the Bedrock® trajectory to supplement spinopelvic fixation and provide permanent SI joint stabilization/ fusion
Teardrop view
Teardrop view
Outlet view
Outlet view
PostOp:1,2
- Resolution of lumbosacral and SI joint pain
- Standing and walking tolerance improved with 5-point VAS improvement (7/10 to 2/10) at 3-month follow-up
1Multilevel deformity constructs have been performed for many years. Reported outcomes reflect entirety of the procedure and cannot be attributed to a single component. This case study represents a single patient’s experience and results may vary.
2Clinical results consistent with early SILVIA (NCT04062630) trial outcomes. SI-BONE data on file.
Healthcare professionals should refer to the Instructions For Use for indications, contraindications, warnings, and precautions at https://si-bone.com/label.
There are potential risks associated with iFuse procedures. They may not be appropriate for all patients and all patients may not benefit.
For information about the risks, visit https://si-bone.com/risks.